Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5767_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
68 Мб
Скачать
150
Y. N. Patrunov et al.
c
d
Fig. 8.12 (continued)
[48]. Besides, the changes were more prominent in the group of patients with severe chronic renal failure than in the group with moderate renal failure.
The data of publications on the quantitative analysis of CEUS for the differential diagnosis of benign and malignant renal tumors are contradic­tory. Probably, it is a consequence of the lack of protocol standardization, the difference in equip­ment, or the small study sample. The washin rate in malignant tumors exceeded the same parameter of benign lesions and also correlated with the
e
degree of differentiation [33]. Peak intensity and time-to-80% on wash-out were also reported to provide signicant differences between clear cell, papillary, and chromophobe renal cell carci­noma subtypes [49]. In small-sized renal cell car­cinomas and AMLs, higher values of enhancement intensity, washout in the late phase, and perile­sional rim-like enhancement were reported [50].
However, currently, the quantitative analysis of renal CEUS remains the subject of scientic study. It is rarely used in clinical practice except for the assessment of the tumor response to therapy.
8 Kidneys andAdrenals
a
151
b
Fig. 8.13 Large renal cell carcinoma, which substitutes 2/3 of the kidney with penetration to retroperitoneal fat. (a) CEUS image. The lesion demonstrates poor enhance­ment with large avascular areas. Some normal paren-
chyma remains in the upper segment of the kidney. (b) TIC shows no enhancement of the lesion (yellow ROI) and typical enhancement of the remaining renal paren­chyma (pink ROI). (c) Venous phase CE-CT
152
Y. N. Patrunov et al.
c
Fig. 8.13 (continued)

8.5 Adrenals

The adrenal glands are situated near the medial aspect of the upper poles of each kidney. They are richly supplied with blood via the superior, mid­dle, and inferior suprarenal arteries, which arise from the inferior phrenic artery, abdominal aorta, and renal artery respectively. These vessels form a plexus within the capsule of the adrenal gland and form small arteries that descend through the cortex and medulla. These arteries compose a capillary network around the medullary secretory cells. The medullary veins merge to a single adre­nal vein, which drains to the inferior vena cava on the right side and the left renal vein on the left.
Adrenals are normally examined together with the kidneys due to the anatomical intimacy. Therefore, most adrenal lesions are detected by chance and called incidentalomas. Imaging meth­ods detect them in 2–4% of the general popula­tion and up to 9–10% in elderly people. The main two tasks with such a lesion are the evaluation of its hormonal activity and the risk of malignancy.
Adrenal adenoma is a dominating lesion, which accounts for about 80% of all incidentalo­mas. Pheochromocytoma, carcinoma, myeloli­poma, cyst, metastasis, etc. exhibit signicantly lower incidence.
CT condently differentiates adrenal ade­noma. A typical adenoma with a native CT scan
has a density from 5 HU to +15 HU.In such cases, which make more than half of all adrenal scans, the introduction of the contrast medium is not required. In other cases, contrast-enhanced CT is necessary with the calculation of relative and absolute washout. Adenomas with high spec­icity demonstrate the values of >40% and >60%, respectively. All lesions that have lower washout values with CE-CT are considered not adenomas, and the specicity of CE-CT in this group is low. MR has similar diagnostic accuracy to CT allowing characterizing adenomas regard­less of their CT enhancement.
With sonography, a similar approach is impos­sible. First of all, the features of the visualization of adrenal glands limit both grayscale and contrast- enhanced ultrasound. Adrenals are located deeply in the retroperitoneal space. Normal adrenals are at and comparable on echo­genicity with the surrounding fat. Therefore, con­ventional US is capable to detect only considerably large adrenal lesions. The left adrenal gland is sur­rounded by gas-containing organs, and the US often fails to determine its masses. The right adre­nal lesions are well visualized with the grayscale US through the liver, but during CEUS, the liver enhancement negatively affects the imaging qual­ity of the right adrenal lesions. Secondly, the microbubbles after bolus injection persist in the blood pool for less than 10min due to their self­destruction, which has a non-linear character. This fact does not permit the interpolation of the CE-CT washout calculation method to CEUS.
EFSUMB guidelines and recommendations for the clinical practice of CEUS in non-hepatic applications (update 2017) devoted only two paragraphs to adrenal diseases [1]. No CEUS cri­teria were reported to reliably differentiate between benign and malignant adrenal gland tumors.
However, simple benign cysts, regardless of the origin, appear nonenhanced in all vascular phases (Fig.8.17, Video 8.15). CEUS identies adrenal cyst, abscess, and hematoma as avascular lesions [51].
Most adrenal adenomas are hypoenhancing in comparison with the liver without any typical vascular pattern [52] (Fig.8.18, Video 8.16).
8 Kidneys andAdrenals
a
b
153
Fig. 8.14 Renal cell carcinoma. (a) CEUS image. The intrarenal lesion of about 5cm in size with a single nonen­hancing uid collection and the otherwise uniform enhancement. (b) CEUS image. The lesion of 3cm in size
with a small nonenhancing area. (c) TIC shape of the lesion enhancement (pink ROI) is similar to the same of the normal renal parenchyma (yellow ROI)
154
Y. N. Patrunov et al.
c
Fig. 8.14 (continued)
Other adrenal lesions, such as pheochromocy­toma, cancer, and metastasis can demonstrate various enhancement patterns and do not have specic signs. CEUS may demonstrate character­istic hypervascularity of some adrenal gland tumors, e.g., pheochromocytoma, which typi­cally also have necrotic regions with no contrast enhancement [1, 52, 53] (Fig.8.19, Video 8.17).
In the adrenal gland, the size of the lesion is important. While the majority of benign masses are smaller than 3cm, the malignant neoplasms and pheochromocytoma by the time of their detection are larger than 3cm. Additionally, the larger the lesion, the more heterogeneously it enhances (Fig.8.20, Video 8.18).
The same principle applies to the metastases in adrenal glands (Fig. 8.21, Video 8.19). Increased and irregular enhancement practically excludes adenoma and is an unfavorable prog­nostic sign. A single metastasis in the adrenal gland is a rare entity, it is usually accompanied by metastases in the other adrenal gland or other organs. The correlation of US ndings with the
patient’s history, clinical, and laboratory data also facilitates the correct conclusion.
The adrenal tumors, which exhibit specic symptoms and were suspected based on clinical and laboratory data, require only precise local­ization. Since CEUS is not a method for the detection of the adrenal mass and can only characterize the already identied lesion, its utilization for the targeted examination of patients with adrenal gland hormone disorders is pointless.
Currently, CEUS of adrenal masses does not reach the diagnostic value of CE-CT and MRI. Moreover, in many cases, it does not provide additional clinically signicant informa­tion to standard sonography with Doppler. However, individual cases may benet from adrenal CEUS.For example, CEUS could easily conrm the absence of contrast enhancement in adrenal hematoma in children and follow them up without risks associated with iodine contrast agents and ionizing radiation of repeated CE-CT examinations [54].
8 Kidneys andAdrenals
155
a
b
c
Fig. 8.15 Renal angiomyolipoma. (a) Grayscale US image reveals a hyperechoic lesion with smooth clear margins. (b) Color Doppler demonstrates the hypovascu­larity of the lesion. (c) Early cortical phase CEUS image demonstrates the beginning of the enhancement of the lesion at the periphery. (d) The late cortical phase CEUS
image demonstrates the gradual uniform enhancement of the lesion from the periphery to the central aspects. (e) Parenchymal phase CEUS shows further enhancement of the lesion. (f) TIC of the lesion enhancement (pink ROI) is attened as compared to the same of the normal renal parenchyma (yellow ROI)
156
Y. N. Patrunov et al.
d
e
Fig. 8.15 (continued)
8 Kidneys andAdrenals
f
157
Fig. 8.15 (continued)
158
ab
Y. N. Patrunov et al.
c
Fig. 8.16 Small renal angiomyolipoma. (a) Grayscale US image reveals typical signs of a renal AML. (b) Color Doppler demonstrates the hypovascularity of the lesion. (c) Cortical phase CEUS image demonstrates poor periph­eral enhancement of the lesion. (d) Parenchymal phase
CEUS shows persisting hypoenhancement. (e) TIC of the lesion enhancement (pink ROI) is low as compared to the same of the normal renal parenchyma (yellow ROI). (f)Native CT demonstrates typical AML with the density of -116HU
8 Kidneys andAdrenals
d
159
e
Fig. 8.16 (continued)